Seasonal Modulation of the 8‐and 24‐Hour Rhythms of Ondansetron Tolerance in Mice

References

• Bernstein B J, Ong C. Efficacy of a single 8‐mg i.v. dose of ondansetron hydrochloride for preventing chemotherapy‐induced emesis. Am. J. Health Syst. Pharm. 2002; 59: 650–652
   PubMedGoogle Scholar
• Boughattas N A, Lévi F. Seasonal modulation of circadian rhythm in murine host tolerance for the new platinum analog, oxaliplatin (l‐OHP). Proceedings of the American Association for Cancer Research, Houston, Texas, 1991; 32: 412
   Google Scholar
• Boughattas N, Lévi F, Fournier C, Hecquet B, Lemaigre G, Roulon A, Mathé G, Reinberg A. Stable circadian mechanisms of toxicity of two platinum analogs (cisplatin and carboplatin) despite repeated dosages in mice. J. Pharm. Exp. Ther. 1990; 255: 672–679
   PubMed Web of Science ®Google Scholar
• Boughattas N A, Ben Attia M, Ixart G, Lemaigre G, Mechkouri M, Reinberg A. Pharmacological blockage of serotonin biosynthesis and circadian changes in oxaliplatin toxicity in rats. Chronobiol. Int. 2002; 19: 1121–1136
   PubMed Web of Science ®Google Scholar
• Brock M A. Seasonal rhythmicity in lymphocyte blastogenesis persists in a constant environment. J. Immunol. 1983; 130: 2586–2588
   PubMed Web of Science ®Google Scholar
• Brock M A. Chronobiology of aging. J. Am. Geriatr. Soc. 1991; 39: 74–91
   PubMed Web of Science ®Google Scholar
• Cal J C, Dorian C, Cambar J. Circadian and circannual changes in nephrotoxic effects of heavy metals and antibiotics. Annu. Rev. Chronopharmacol. 1986; 2: 143–176
   Google Scholar
• Cambar J, L'Azou B, Cal J C. Chronotoxicology. Biologic Rhythms in Clinical and Laboratory Medicine, Y Touitou, E Haus. Springer‐Verlag, Berlin 1994; 138–150
   Google Scholar
• Canaple L, Kakizawa T, Laudet V. The days and nights of cancer cells. Cancer Res. 2003; 63: 7545–7552
   PubMed Web of Science ®Google Scholar
• Costall B, Domeney A M, Naylor R J, Tattersall F D. 5‐Hydroxytryptamine M‐receptor antagonism to prevent cisplatin‐induced emesis. Neuropharmacology 1986; 25: 959–961
   PubMed Web of Science ®Google Scholar
• Costall B, Jones B J, Kelly M E, Naylor R J, Oakley N R, Onaivi E S, Tyers M B. The effects of ondansetron (GR38032F) in rats and mice treated subchronically with diazepam. Pharmacol. Biochem. Behav. 1989; 34: 769–778
   PubMedGoogle Scholar
• Costall B, Jones B J, Kelly M E, Naylor R J, Onaivi E S, Tyers M B. Ondansetron inhibits a behavioural consequence of withdrawing from drugs of abuse. Pharmacol. Biochem. Behav. 1990; 36: 339–344
   PubMed Web of Science ®Google Scholar
• Dardente H, Cermakian N. Molecular circadian rhythms in central and peripheral clocks in mammals. Chronobiol. Int. 2007; 24: 195–213
   PubMed Web of Science ®Google Scholar
• Davis D E. Hibernation and circannual rhythms of food consumption in marmots and ground squirrels. Q. Rev. Biol. 1976; 51: 477–514
   PubMed Web of Science ®Google Scholar
• De Prins J, Waldura J. Sightseeing around the single cosinor. Chronobiol. Int. 1993; 10: 395–400
   PubMed Web of Science ®Google Scholar
• Dupré S M, Loudon A S. Circannual clocks: Annual timers unraveled in sheep. Curr. Biol. 2007; 20: R216–R217
   Google Scholar
• Edgar D M, Miller J D, Prosser R A, Dean R R, Dement W C. Serotonin and the mammalian circadian system: Phase shifting rat behavioural rhythms with serotonergic agonists. J. Biol. Rhythms 1993; 8: 17–31
   PubMed Web of Science ®Google Scholar
• Focan C. Chronobiologic concepts underlying the chronotherapy of human lung cancer. Chronobiol. Int. 2002; 19: 253–273
   PubMed Web of Science ®Google Scholar
• Giacchetti S. Chronotherapy of colorectal cancer. Chronobiol. Int. 2002; 19: 21–41
   PubMedGoogle Scholar
• Goodin S, Cunningham R. 5‐HT3‐receptor antagonists for the treatment of nausea and vomiting: A reappraisal of their side‐effect profile. Oncologist 2002; 7: 424–436
   PubMed Web of Science ®Google Scholar
• Gwinner E. Circannual rhythms in birds. Curr. Opin. Neurobiol. 2003; 13: 770–778
   PubMed Web of Science ®Google Scholar
• Haus E. Chronobiology of the immune system. In the Committee on Military Nutrition Research, Institute of Medicine. Military Strategies for Sustainment of Nutrition and Immune Function in the Field: Nutrition and Immune Function. National Academy Press, Washington, D.C. 1999; 437–496
   Google Scholar
• Haus E, Nicolau C Y. Rhythms in bone marrow cell proliferation: How to apply to the chronotherapy of cancer?. Chronobiol. Int. 1992; 9: 393–398
   PubMedGoogle Scholar
• Haus E, Touitou Y. Principles of clinical chronobiology. Biologic Rhythms in Clinical and Laboratory Medicine, Y Touitou, E Haus. Springer‐Verlag, Heidelberg 1994; 6–34
   Google Scholar
• Haus E, Halberg F, Scheving L E, Pauly J E, Cardoso S, Kuhl J FW, Sothem R B, Shiotsuka R N, Hwang D S. Increased tolerance of leukemic mice to arabinosyl cytosine with schedule adjusted to circadian system. Science 1972; 177: 80–82
   PubMed Web of Science ®Google Scholar
• Haus E, Halberg F, Kuhl J FW, Lakatua D J. Chronopharmacology in animals. Chronobiologia 1974; 1: 122–156
   PubMedGoogle Scholar
• Haus E, Lakatua D J, Sackett‐Lundeen L, White M. Circannual variation of intestinal cell proliferation in BDF male mice on three lighting regimens. Chronobiol. Int. 1984; 1: 185–194
   PubMedGoogle Scholar
• Hendrie C A. The 5‐HT3 antagonist GR38032F is highly toxic in DBA/2 mice. Psychopharmacology (Berlin) 1990; 101: 429–430
   PubMedGoogle Scholar
• Hrushesky W J. Bone marrow suppression from doxorubicin and cisdiammine‐dichloroplatinum is substantially dependent upon both circadian and circannual state of administration. Ann. NY Acad. Sci. 1982; 397: 293–295
   Web of Science ®Google Scholar
• Hrushesky W J. Circadian timing of cancer chemotherapy. Science 1985; 228: 73–75
   PubMed Web of Science ®Google Scholar
• Hrushesky W J, Bjarnason G A. Circadian cancer therapy. J. Clin. Oncol. 1993; 11: 1403–1417
   PubMed Web of Science ®Google Scholar
• Ixart G, Szafarczyk A, Malaval F, Assenmacher I. Impairment of the ether stress‐induced ACTH surge in rats by ablation of the suprachiasmatic nuclei or by i.p. injection of p‐chlorophenylalanine. Neuroendocrinol. Lett. 1985; 7: 171–174
   Web of Science ®Google Scholar
• Kalsbeek A, Perreau‐Lenz S, Buijs R M. A network of (autonomic) clock outputs. Chronobiol. Int. 2006; 23: 521–535
   PubMed Web of Science ®Google Scholar
• Khedhaier A, Ben Attia M, Gadacha W, Sani M, Bouzouita K, Chouchane L, Mechkouri M, Reinberg A, Boughattas N A. Circadian rhythms in toxic effects of the serotonin antagonist ondansetron in mice. Chronobiol. Int. 2003a; 20: 1111–1116
   Google Scholar
• Khedhaier A, Ben Attia M, Sani M, Moussa Soumey B, Trabelsi H, Bouzouita K, Chouchane L, Boughattas N A. Effet de l'ondansétron sur les rythmes de toxicité de l'oxaliplatine chez la souris. Mécanismes et Physiopathologie des Fonctions Rythmiques, Y Touitou. Vernazobres‐Grego Publications, Paris 2003b; 389–396
   Google Scholar
• Kobayashi M, To H, Tokue A, Fujimura A, Kobayashi E. Cisplatin‐induced vomiting depends on circadian timing. Chronobiol. Int. 2001; 18: 851–863
   PubMed Web of Science ®Google Scholar
• Kobayashi M, Wood P A, Hrushesky W JM. Circadian chronotherapy for gynecological and genitourinary cancers. Chronobiol. Int. 2002; 19: 237–251
   PubMed Web of Science ®Google Scholar
• Lévi F. Chronopharmacologie de trois agents doués d'activité anti‐cancereuse chez le rat et la souris. Chronoéfficacité et chronotolerance. Université Pierre et Marie Curie, Paris VI. 1982; 217, Ph.D. Thesis
   Google Scholar
• Lévi F. Chronotherapeutics: The relevance of timing in cancer therapy. Cancer Causes Control 2006; 17: 611–621
   PubMed Web of Science ®Google Scholar
• Lévi F, Blazsek I, Ferlé‐Vidovic A. Circadian and seasonal rhythms in murine bone marrow colony‐forming cells affect tolerance for the anti‐cancer agent 4‐0 tetrahydropyranyladriamycin (THP). Exp. Hematol. 1988; 16: 696–701
   PubMed Web of Science ®Google Scholar
• Lincoln G A, Andersson H, Hazlerigg D. Clock genes and long‐term regulation of prolactin secretion: Evidence for a photoperiod/circannual timer in the pars tuberalis. J. Neuroendocrinol. 2003; 15: 390–397
   PubMed Web of Science ®Google Scholar
• Lindley C, Blower P. Oral serotonin type 3‐receptor antagonists for prevention of chemotherapy‐induced emesis. Am. J. Health Syst. Pharm. 2000; 57: 1685–1697
   PubMed Web of Science ®Google Scholar
• Marty M, Pouillart P, Scholl S, Droz J P, Azab M, Brion N, Pujade‐Lauraine E, Paule B, Paes D, Bons J. Comparison of the 5‐hydroxytryptamine 3 (serotonin) antagonist ondansetron (GR 38032F) with high‐dose metoclopramide in the control of cisplatin‐induced emesis. N. Engl. J. Med. 1990; 322: 816–821
   PubMed Web of Science ®Google Scholar
• Miner W D, Sanger G J. Inhibition of cisplatin‐induced vomiting by selective 5‐hydroxytryptamine M‐receptor antagonism. Br. J. Pharmacol. 1986; 88: 497–499
   PubMed Web of Science ®Google Scholar
• Moore R Y, Halaris A E, Jones B E. Serotonin neurons of the midbrain raphe: Ascending projections. J. Comp. Neurol. 1978; 180: 417–438
   PubMed Web of Science ®Google Scholar
• Morin L P, Blanchard J. Depletion of brain serotonin by 5‐7‐DHT modifies hamster circadian rhythm response to light. Brain Res. 1991; 566: 173–185
   PubMed Web of Science ®Google Scholar
• Mormont C, von Roemeling R, Sothern R B, Berestka J S, Langevin T R, Wick M, Hrushesky W J. Circadian rhythm and seasonal dependence in the toxicological response of mice to epirubicin. Invest. New Drugs. 1988; 6: 273–283
   PubMedGoogle Scholar
• Mormont C, Boughattas N A, Lévi F. Mechanisms of circadian rhythms in toxicity and efficacy of anticancer drugs: Relevance for the developement of new analogs. Cellular and Biochemical Aspects of Chronopharmacology, B Lemmer. Marcel Dekker, New York 1989; 19: 395–435
   Google Scholar
• Nelson W, Tong Y L, Lee J K, Halberg F. Methods for cosinor rhythmometry. Chronobiologia 1979; 6: 305–323
   PubMedGoogle Scholar
• Pengelly E T. Circannual Clocks: Annual Biological Rhythms. Academic Press, New York 1974; 523
   Google Scholar
• Rea M A, Barrera J, Glass J D, Gannon R L. Serotonergic potentiation of photic phase shifts of the circadian activity rhythm. Neuroreport 1995; 6: 1289–1292
   Web of Science ®Google Scholar
• Reinberg A, Smolensky M H. Investigate methodology for chronobiology. Biological Rhythms and Medicine. Cellular, Metabolic, Physiopathologic and Pharmacologic Aspects, A Reinberg, M H Smolensky. Springer‐Verlag, New York 1983; 20–46
   Google Scholar
• Reinberg A, Le Fur I, Tschachler E. Problems related to circadian rhythms in human skin and their validation. J. Invest. Dermatol. 1998; 111: 708–709
   PubMed Web of Science ®Google Scholar
• Simpson K H, Hicks F M. Clinical pharmacokinetics of ondansetron. A review. J. Pharm. Pharmacol. Ther. 1996; 48: 774–781
   PubMed Web of Science ®Google Scholar
• Stables R, Andrews P L, Bailey H E, Costall B, Gunning S J, Hawthorn J, Naylor R J, Tyers M B. Antiemetic properties of the 5‐HT3‐receptor antagonist, GR38032F. Cancer Treat. Rev. 1987; 14: 333–336
   PubMed Web of Science ®Google Scholar
• Touitou Y, Smolensky M H, Portaluppi F. Ethics, standards, and procedures of animal and human chronobiology research. Chronobiol. Int. 2006; 23: 1083–1096
   PubMed Web of Science ®Google Scholar
• Wood P A, Hrushesky W J. Circadian rhythms and cancer chemotherapy. Crit. Rev. Eukaryot. Gene Exp. 1996; 6: 299–343
   PubMedGoogle Scholar